| Filed | Description | |
|---|---|---|
| 4/16/24 | 1.02 Agreement Terminated | → |
| 1/11/24 | 1.01 Material Agreement | → |
| 10/20/23 | 1.012.03 Material Agreement · New Debt Obligation | → |
| 10/19/23 | 1.01 Material Agreement | → |
| 8/16/23 | 1.01 Material Agreement | → |
| 7/6/23 | 1.01 Material Agreement | → |
| ↓ 1 more | ||
Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina.